Nausea, vomiting, and digestive discomfort are among the most common GLP-1 side effects. Here’s why Ozempic and Victoza affect digestion differently — and why some patients tolerate one medication better than the other.
Victoza is widely used for type 2 diabetes, but many patients also experience weight loss during treatment. Learn how liraglutide affects appetite, digestion, and metabolic health — plus the side effects and safety warnings patients should understand.
Saxenda introduced GLP-1 weight-loss therapy to mainstream obesity medicine, but Wegovy dramatically changed expectations with stronger appetite suppression, weekly dosing, and substantially greater weight-loss results. Here’s why semaglutide overtook liraglutide in modern obesity treatment.
Mounjaro and Wegovy are leading GLP-1–based therapies for weight loss. This evidence-based comparison explores effectiveness, safety, and clinical differences.